Oppenheimer raised its price target on CME Group Inc. (NASDAQ:CME) to $300 from $282, maintaining an Outperform rating, as ...

In recent trading, shares of CME Group Inc (Symbol: CME) have crossed above the average analyst 12-month target price of $270.39, changing hands for $272.36/share. When a stock reaches the target ...

Oppenheimer raised the firm’s price target on CME Group to $245 from $228 and keeps an Outperform rating on the shares. The firm notes CME has benefited from the uncertainty on the pace of rate ...

The latest price target for CME Group (NASDAQ:CME) was reported by Oppenheimer on June 4, 2025. The analyst firm set a price target for $300.00 expecting CME to rise to within 12 months (a ...

Morgan Stanley raised the firm’s price target on CME Group to $233 from $210 and keeps an Equal Weight rating on the shares. In a preview for the Brokers & Exchanges group, the analyst says it ...

The latest price target for CME Group (NASDAQ:CME) was reported by UBS on April 25, 2025. The analyst firm set a price target for $305.00 expecting CME to rise to within 12 months (a possible 5.55 ...

BofA raised the firm’s price target on CME Group (CME) to $219 from $200 and keeps an Underperform rating on the shares. The increasingly uncertain macroeconomic and geopolitical backdrop ...

Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and lowered their price target for the company from $255.00 to $250.00 in a research report on Monday ...

Deutsche Bank lowered the firm’s price target on CME Group (CME) to $226 from $227 and keeps a Hold rating on the shares. Following the U.S. elections, the firm made several updates to its macro ...

CME Group (NASDAQ:CME – Free Report) had its price target upped by Royal Bank of Canada from $235.00 to $269.00 in a research note published on Thursday,Benzinga reports.They currently have a ...